Dr. Divyanshu (Div) Dubey
Assistant Professor & Senior Associate Consultant, Division of Clinical Biochemistry & Immunology, Department of Laboratory Medicine and Pathology
Assistant Professor of Neurology & Senior Associate Consultant, Section of Neuromuscular Diseases, Department of Neurology
Mayo Clinic, USA
Dr. Divyanshu Dubey has a patent pending for Kelch-like protein 11 as a marker of neurological autoimmunity and has received research support from Grifols, Center of Multiple Sclerosis and Autoimmune Neurology, Center for Clinical and Translational Science.
Dr. Dubey has consulted for UCB and Astellas. He has participated in UCB Advisory Board Meeting in Lyon, France on September 23, 2019. Dr. Dubey is on the editorial board of Journal of Clinical Medicine.
Focus areas include:
Autoantibody biomarkers. Dr. Dubey's laboratory research focuses on identifying novel autoantibodies for diagnosis of autoimmune or paraneoplastic neurological syndromes. He also evaluates the clinical and oncologic associations of previously described neural-specific antibodies.
Epidemiology. Dr. Dubey is working to establish accurate incidence and prevalence of autoimmune neurological disorders through population-based studies.
Autoimmune epilepsy. Dr. Dubey works to evaluate the role of autoimmunity among patients with epilepsy of unknown etiology. He also contributes to creating and validating predictive models for diagnosis and management of autoimmune epilepsy.
Paraneoplastic neuropathies. An additional area of focus for Dr. Dubey is studying and describing clinical and electrodiagnostic phenotypes of paraneoplastic neuropathies.
